Locally Recurrent Prostate Cancer

3

Review clinical trials related to Locally Recurrent Prostate Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.

This is a multi-center clinical study enrolling up to 10 participants. The purpose of this study is to assess the feasibility and safety of intratumoral DaRT seeds implantation for the treatment of locally recurrent prostate cancer. Secondary objectives are to 1. To evaluate feasibility of interstitial radiotherapy using DaRT seeds. Feasibility will be determined according to the rate of successful placement of DaRT seeds via imaging \[Timeframe: immediately following the insertion procedure 2. To assess the impact of DaRT seeds on patient reported quality of life.

Participants needed: 10
Trial details
Age: 18-120Biological sex: MaleType: InterventionalSponsor: Alpha Tau Medical LTD.Updated: Jun 16, 2026Locations: 1
Eligibility criteria

Histologically confirmed locally recurrent prostate adenocarcinoma cancer confin... [+11]

N1 or M1 disease [+9]

Status: Not yet recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer

This is a multi-center clinical study enrolling up to 12 participants . The primary objective of the study is to evaluate the safety of Alpha DaRT for the treatment of locally recurrent prostate cancer . The secondary objectives of the study is to evaluate the efficacy of the Alpha DaRT sources in locally recurrent prostate cancer patients assessed by biochemical and clinical evaluation of disease progression as well as overall survival

Participants needed: 12
Trial details
Age: 40-120Biological sex: MaleType: InterventionalSponsor: Alpha Tau Medical LTD.Updated: Apr 6, 2026
Eligibility criteria

Histologically and/or cytologically proven prostate adenocarcinoma [+17]

Concomitant immunotherapy within the past 4 weeks. [+12]

Status: Recruiting

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.

Participants needed: 36
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Royal North Shore HospitalUpdated: Feb 6, 2026Locations: 1
Eligibility criteria

Men > 4yrs from external beam radiotherapy (EBRT) meeting the Phoenix definition... [+4]

Recurrence in immediate proximity to rectum (unless able to have hydrogel) [+3]